Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

A melanin-independent interaction between Mc1r and Met signaling pathways is required for HGF-dependent melanoma.

Wolnicka-Glubisz A, Strickland FM, Wielgus A, Anver M, Merlino G, De Fabo EC, Noonan FP.

Int J Cancer. 2015 Feb 15;136(4):752-60. doi: 10.1002/ijc.29050. Epub 2014 Jul 7.

2.

Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment.

Noonan FP, Zaidi MR, Wolnicka-Glubisz A, Anver MR, Bahn J, Wielgus A, Cadet J, Douki T, Mouret S, Tucker MA, Popratiloff A, Merlino G, De Fabo EC.

Nat Commun. 2012 Jun 6;3:884. doi: 10.1038/ncomms1893.

3.

Shedding light on melanocyte pathobiology in vivo.

Zaidi MR, De Fabo EC, Noonan FP, Merlino G.

Cancer Res. 2012 Apr 1;72(7):1591-5. doi: 10.1158/0008-5472.CAN-11-2586. Epub 2012 Mar 15. Review.

4.

Interferon-γ links ultraviolet radiation to melanomagenesis in mice.

Zaidi MR, Davis S, Noonan FP, Graff-Cherry C, Hawley TS, Walker RL, Feigenbaum L, Fuchs E, Lyakh L, Young HA, Hornyak TJ, Arnheiter H, Trinchieri G, Meltzer PS, De Fabo EC, Merlino G.

Nature. 2011 Jan 27;469(7331):548-53. doi: 10.1038/nature09666. Epub 2011 Jan 19.

5.

Sunscreen prevention of melanoma in man and mouse.

Klug HL, Tooze JA, Graff-Cherry C, Anver MR, Noonan FP, Fears TR, Tucker MA, De Fabo EC, Merlino G.

Pigment Cell Melanoma Res. 2010 Dec;23(6):835-7. doi: 10.1111/j.1755-148X.2010.00756.x. Epub 2010 Aug 20. No abstract available.

6.

UVB and UVA initiate different pathways to p53-dependent apoptosis in melanocytes.

Noonan FP, De Fabo EC.

J Invest Dermatol. 2009 Jul;129(7):1608-10. doi: 10.1038/jid.2009.116.

7.

The effects on human health from stratospheric ozone depletion and its interactions with climate change.

Norval M, Cullen AP, de Gruijl FR, Longstreth J, Takizawa Y, Lucas RM, Noonan FP, van der Leun JC.

Photochem Photobiol Sci. 2007 Mar;6(3):232-51. Epub 2007 Jan 25.

PMID:
17344960
8.

Environmental effects of ozone depletion: 2006 assessment: interactions of ozone depletion and climate change. Executive summary.

Andrady AL, Aucamp PJ, Bais AF, Ballaré CL, Bjorn LO, Bornman JF, Caldwell MM, Cullen AP, de Gruijl FR, Erickson DJ 3rd, Flint SD, Häder DP, Hamid HS, Ilyas M, Kulandaivelu G, Kumar HD, McKenzie RL, Longstreth J, Lucas RM, Noonan FP, Norval M, Paul ND, Smith RC, Soloman KR, Sulzberger B, Takizawa Y, Tang X, Torikai A, van der Leun JC, Wilson SR, Worrest RC, Zepp RG.

Photochem Photobiol Sci. 2007 Mar;6(3):212-7. Epub 2007 Feb 15. No abstract available.

PMID:
17344958
9.

Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.

Wolnicka-Glubisz A, Noonan FP.

Photochem Photobiol Sci. 2006 Feb;5(2):254-60. Epub 2005 Jul 27. Review.

PMID:
16465311
10.

Animal models of melanoma.

Ha L, Noonan FP, De Fabo EC, Merlino G.

J Investig Dermatol Symp Proc. 2005 Nov;10(2):86-8. No abstract available.

11.

SCA-1+ cells with an adipocyte phenotype in neonatal mouse skin.

Wolnicka-Glubisz A, King W, Noonan FP.

J Invest Dermatol. 2005 Aug;125(2):383-5. No abstract available.

12.

Ultraviolet B but not ultraviolet A radiation initiates melanoma.

De Fabo EC, Noonan FP, Fears T, Merlino G.

Cancer Res. 2004 Sep 15;64(18):6372-6.

13.

Mice with genetically determined high susceptibility to ultraviolet (UV)-induced immunosuppression show enhanced UV carcinogenesis.

Noonan FP, Muller HK, Fears TR, Kusewitt DF, Johnson TM, De Fabo EC.

J Invest Dermatol. 2003 Nov;121(5):1175-81.

14.

Ultraviolet radiation and cutaneous malignant melanoma.

Jhappan C, Noonan FP, Merlino G.

Oncogene. 2003 May 19;22(20):3099-112. Review.

PMID:
12789287
15.

Modeling gene-environment interactions in malignant melanoma.

Merlino G, Noonan FP.

Trends Mol Med. 2003 Mar;9(3):102-8. Review.

PMID:
12657431
16.

Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events.

Noonan FP, Dudek J, Merlino G, De Fabo EC.

Pigment Cell Res. 2003 Feb;16(1):16-25. Review.

PMID:
12519121
17.

Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.

Recio JA, Noonan FP, Takayama H, Anver MR, Duray P, Rush WL, Lindner G, De Fabo EC, DePinho RA, Merlino G.

Cancer Res. 2002 Nov 15;62(22):6724-30.

18.

Neonatal sunburn and melanoma in mice.

Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G.

Nature. 2001 Sep 20;413(6853):271-2.

PMID:
11565020
19.

Genetic control of susceptibility to UV-induced immunosuppression by interacting quantitative trait loci.

Clemens KE, Churchill G, Bhatt N, Richardson K, Noonan FP.

Genes Immun. 2000;1(4):251-9.

20.

Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice.

Noonan FP, Otsuka T, Bang S, Anver MR, Merlino G.

Cancer Res. 2000 Jul 15;60(14):3738-43.

21.

Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit.

Hart PH, Grimbaldeston MA, Hosszu EK, Swift GJ, Noonan FP, Finlay-Jones JJ.

Immunology. 1999 Nov;98(3):352-6.

22.

Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice.

Hart PH, Grimbaldeston MA, Swift GJ, Jaksic A, Noonan FP, Finlay-Jones JJ.

J Exp Med. 1998 Jun 15;187(12):2045-53.

23.

Urocanic acid does not photobind to DNA in mice irradiated with immunosuppressive doses of UVB.

IJland SA, Noonan FP, Ceryak S, Steenvoorden DP, Bouscarel B, Hug D, Beijersbergen van Henegouwen GM, De Fabo EC.

Photochem Photobiol. 1998 Feb;67(2):222-6.

PMID:
9487799
24.

Dietary beta-carotene and ultraviolet-induced immunosuppression.

Noonan FP, Webber LJ, De Fabo EC, Hoffman HA, Bendich A, Mathews-Roth M.

Clin Exp Immunol. 1996 Jan;103(1):54-60.

25.

UVB-induced immune suppression and infection with Schistosoma mansoni.

Noonan FP, Lewis FA.

Photochem Photobiol. 1995 Jan;61(1):99-105.

PMID:
7899499
26.

Susceptibility to immunosuppression by ultraviolet B radiation in the mouse.

Noonan FP, Hoffman HA.

Immunogenetics. 1994;39(1):29-39.

PMID:
8225436
27.

Control of UVB immunosuppression in the mouse by autosomal and sex-linked genes.

Noonan FP, Hoffman HA.

Immunogenetics. 1994;40(4):247-56.

PMID:
8082890
28.

Immunosuppression by ultraviolet B radiation: initiation by urocanic acid.

Noonan FP, De Fabo EC.

Immunol Today. 1992 Jul;13(7):250-4. Review.

PMID:
1388651
30.
31.

Ultraviolet-B dose-response curves for local and systemic immunosuppression are identical.

Noonan FP, De Fabo EC.

Photochem Photobiol. 1990 Oct;52(4):801-10.

PMID:
2089429
32.

A single dose of UV radiation suppresses delayed type hypersensitivity responses to alloantigens and prolongs heart allograft survival in mice.

Mottram PL, Mirisklavos A, Clunie GJ, Noonan FP.

Immunol Cell Biol. 1988 Oct-Dec;66 ( Pt 5-6):377-85.

PMID:
2976024
34.

Cells infiltrating inflamed and vascularized corneas.

Williams KA, Ash JK, Mann TS, Noonan FP, Coster DJ.

Transplant Proc. 1987 Apr;19(2):2889-91. No abstract available.

PMID:
3551231
35.

Immune suppression by ultraviolet radiation and its role in ultraviolet radiation induced carcinogenesis in mice.

Noonan FP, De Fabo EC.

Australas J Dermatol. 1985 Apr;26(1):4-8. No abstract available.

PMID:
4062748
39.

Suppression of contact hypersensitivity by UV radiation and its relationship to UV-induced suppression of tumor immunity.

Noonan FP, De Fabo EC, Kripke ML.

Photochem Photobiol. 1981 Dec;34(6):683-9. No abstract available.

PMID:
6458828
40.
41.

Suppression of contact hypersensitivity by ultraviolet radiation: an experimental model.

Noonan FP, De Fabo EC, Kripke ML.

Springer Semin Immunopathol. 1981;4(3):293-304. No abstract available.

PMID:
6461932
42.

Genetic restriction of the serum factor mediating tolerance in trinitrochlorobenzene hypersensitivity.

Noonan FP, Halliday WJ.

Cell Immunol. 1980 Mar 1;50(1):41-7. No abstract available.

PMID:
7397783
43.

Early pregnancy factor is immunosuppressive.

Noonan FP, Halliday WJ, Morton H, Clunie GJ.

Nature. 1979 Apr 12;278(5705):649-51. No abstract available.

PMID:
313010
44.

Studies of contact hypersensitivity and tolerance in vivo and in vitro. II. Regulation by serum factors.

Halliday WJ, Noonan FP.

Int Arch Allergy Appl Immunol. 1978;56(6):532-42. No abstract available.

PMID:
631922
46.

Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.

Noonan FP, Halliday WJ, Wall DR, Clunie GJ.

Cancer Res. 1977 Aug;37(8 Pt 1):2473-80.

47.

End thoracic duct presurres in man.

Isbister WH, Balderson G, Noonan FP, Halliday WJ, Clunie GJ.

Aust N Z J Surg. 1975 Nov;45(4):422-4.

PMID:
1061567
48.

Human thoracic duct cannulation: manipulation of tumor-specific blocking factors in a patient with malignant melanoma.

Isbister WH, Noonan FP, Halliday WJ, Clunie GJ.

Cancer. 1975 May;35(5):1465-71.

PMID:
1122496
49.

Control of tumor growth in mice by thoracic duct drainage: relationship to blocking factor in lymph.

Noonan FP, Gardner MA, Clunie GJ, Isbister WH, Halliday WJ.

Int J Cancer. 1974 May 15;13(5):640-9. No abstract available.

PMID:
4843878
50.

Proceedings: Manipulation of blocking factor and its effect on tumour growth in mice.

Clunie CJ, Noonan FP, Gardner MA, Halliday WJ, Isbister WH, Burnett W.

Br J Surg. 1974 Apr;61(4):322. No abstract available.

PMID:
4832651

Supplemental Content

Loading ...
Support Center